Phase 2 Epithelial Cancer Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Agnostic Therapy in Rare Solid Tumors
Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting
Phase 1Phase 2
The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer
Ovarian CancerFallopian Tube CancerEpithelial Cancer
The Netherlands Cancer Institute55 enrolled1 locationNCT07460180
Active
Phase 2
Phase II basket study of an ARomatase inhibitor plus PI3KCA inhibitor or CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic Gynaecological Neoplasms (PARAGON-II)
Platinum resistant high-grade epithelial cancers of fallopian tubeOther gynaecological cancers (excluding endometrial cancers)Endometrial stromal sarcomas+5 more
The University of Sydney182 enrolled17 locationsACTRN12621000639820